Neuro Congress 2020 is an elite stage to unite overall eminent researchers in the field of Neuroscience Brain, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies. The aim of this conference is to stimulate new ideas in the various fields of neurology and neurological research from brain imaging to neural engineering; this will help in the analysis and select the prosthetic to help the patients. Other reasons are, gathering of world-class researchers and budding talent from across the globe, showcase your research and get world recognition, avail chances to interact with world-renowned scientists, perfectly designed schedule: Workshop, Expo areas, Brain sessions and many more, platform to network with fellow primary care clinicians, educational workshops on diagnosis and treatment of Neurological Diseases.
Why to Attend?
Neuro Congress 2020 will be operated by world-class experts in the field of Neurology and Neuroscience. International symposiums, B2B meetings, and workshops will also be organized to discuss the specific topics in the field of Neurology like Pediatric Neurology, Dementia, Neurological Diseases, Brain Disorders and Pathophysiology Traumatic Brain Injury, Neuro Oncology and CNS, Neuroscience and Artificial intelligence and many more. The main aim of Neuro Congress 2020 is to promote awareness and enhance research aimed at developing solutions for the various Neuroscience challenges encountered in the recent era.
Apart from collaboration we will also provide you with an opportunity to interact and learn from our Business partners, Exhibitors and Sponsors who were esteemed in the field of Healthcare. This would also offers a chance to speak with them personally and evaluate if they could be helpful for your networking practices. You can also learn from each other during Networking Breaks.
With great pleasure, we invite you to participate in the 4th International Conference on Neurology and Brain Disorders which is going to be held on April 20-21, 2020 at Bangkok, Thailand. The topic of the conference covers a wide range of critically important sessions related to Neuroscience and advancement.
Neurological disorders are illnesses of the spine, brain and the nerves that connect them. There is adequate confirmation that pinpoints neurological disorders as one of the biggest threat to public health. There are more than 600 diseases of the nervous system, such as Alzheimer's disease, Brain tumors, Epilepsy, Parkinson's disease, and Stroke as well as less familiar ones such as front temporal dementia. In the present-day scenario, a wide population of mankind is plagued by mental and neurological illnesses, with almost 165 million people or 38 percent of the population suffering each year from a brain disorder. With just about a third of cases accepting the treatment or medication needed. Mental illnesses cause a huge economic and social burden. It found the cost burden of these and neurological disorders amounted to about 386 billion euros a year. Every year an expected 6.8 million people die because of neurological disorders.
Keeping in mind the end goal to quicken the examination in the field of Neuroscience, we composes diverse meeting arrangement around the world. The aim of the conference conducted by us is to spread awareness regarding the subject and to excite the researcher’s mind, which will definitely influence the current research session on Neurology.
Neurology might be characterized as the finding and treatment of scatters of the sensory system, which incorporates the cerebrum and spinal rope. The market examination of neurology addresses the biggest and undiscovered market in the prescription area. This assessed showcase investigation is relying upon the likelihood of endorsement and offers of items in late-stage change, statistic patterns and advancing of an item. Rising and creating markets at the end of the day helps incomes. Central Nervous System (CNS) therapeutics includes approximately 15% of total pharmaceutical arrangements, about $30 billion around the globe.
